LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.8550
+0.0018 (0.21%)
At close: Jan 30, 2026
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $35.23 million as of January 30, 2026. Its market cap has decreased by -44.55% in one year.
Market Cap
35.23M
Enterprise Value
88.47M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.85
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from 227.76M to 35.23M, a decrease of -84.53%. That is a compound annual growth rate of -34.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 35.23M | 1.78% |
| Dec 31, 2025 | 34.62M | -47.56% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
| Aug 5, 2021 | 227.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 51.78M |
| Arch Biopartners | 51.20M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 43.45M |
| ZIVO Bioscience | 41.48M |
| Oncotelic Therapeutics | 39.96M |
| Ayala Pharmaceuticals | 33.80M |
| Harvard Apparatus Regenerative Technology | 29.54M |